Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

被引：0

作者：

F. Wilford Germino

Joel M. Neutel

Robert Dubiel

Jen-Fue Maa

Kathleen J. Chavanu

机构：

[1] Orland Primary Care Specialists,Department of Internal Medicine

[2] Orange County Research Center,undefined

[3] Daiichi Sankyo,undefined

[4] Inc.,undefined

来源：

American Journal of Cardiovascular Drugs | 2012年 / 12卷 / 5期

关键词：

Ambulatory Blood Pressure; Ambulatory Blood Pressure Monitoring; HCTZ; Olmesartan Medoxomil; Blood Pressure Goal;

D O I：

10.1007/BF03261841

中图分类号：

学科分类号：

摘要：

Background: The incidence of hypertension, particularly isolated systolic hypertension, increases with in-creasing age, as does the risk of fatal cardiovascular disease. A combination antihypertensive therapy regimen may be required to reach recommended BP goals in older patients.

引用

页码：325 / 333

页数：8

共 50 条

[21] Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy
Zhu, Jun-Ren
Zhang, Shu-Yang
Gao, Ping-Jin
ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (12) : 1588 - 1598
[22] Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy
Jun-Ren Zhu
Shu-Yang Zhang
Ping-Jin Gao
Archives of Pharmacal Research, 2014, 37 : 1588 - 1598
[23] Efficacy of valsartan in patients aged ≥65 years with systolic hypertension
Neutel, JM
Bedigian, MP
CLINICAL THERAPEUTICS, 2000, 22 (08) : 961 - 969
[24] Efficacy of olmesartan medoxomil (OLM) and OLM/hydrochlorothiazide (HCTZ) in achieving blood pressure (BP) goals in black patients with stage 2 systolic hypertension
Saunders, E.
Neutel, J. M.
Bailey, W.
Jones, M.
Dubiel, R.
Walker, F.
ETHNICITY & DISEASE, 2006, 16 (03) : S58 - S58
[25] TRIPLE-DRUG, FIXED-DOSE COMBINATIONS FOR THE TREATMENT OF HYPERTENSION: FOCUS ON OLMESARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE COMBINATION
Chrysant, S. G.
DRUGS OF TODAY, 2011, 47 (03) : 197 - 206
[26] Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension
Rakugi, Hiromi
Tsuchihashi, Takuya
Shimada, Kazuyuki
Numaguchi, Hirotaka
Nishida, Chisato
Yamaguchi, Hiroya
Shirakawa, Masayoshi
Azuma, Kyoichi
Fujita, Kenji P.
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (03) : 260 - 266
[27] Population Pharmacokinetics and Exposure-Response of a Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With Stage 2 Hypertension
Tsai, Max C.
Wu, Jingtao
Kupfer, Stuart
Vakilynejad, Majid
JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (08): : 988 - 998
[28] Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
Ruilope, Luis M.
VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (06) : 1237 - 1248
[29] Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension
Fogari, Roberto
Taddei, Stefano
Holm-Bentzen, Merete
Baszak, Jacek
Melani, Lorenzo
Schumacher, Kai
CLINICAL DRUG INVESTIGATION, 2010, 30 (09) : 581 - 597
[30] Comparison of Aliskiren/Hydrochlorothiazide Combination Therapy With Hydrochlorothiazide Monotherapy in Older Patients With Stage 2 Systolic Hypertension: Results of the ACTION Study
Basile, Jan
Babazadeh, Simon
Lillestol, Michael
Botha, Jaco
Yurkovic, Carol
Weitzman, Richard
JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (03): : 162 - 169

← 1 2 3 4 5 →